title: Effects of immunosuppression with cyclosporine in insulin-dependent diabetes mellitus of recent onset: the Canadian open study at 44 months.
authors.affiliation: University Hospital, Robarts Research Institute, London, Ontario, Canada.
authors.forename: J
authors.initials: J
authors.lastname: Dupré
authors.forename: C R
authors.initials: CR
authors.lastname: Stiller
authors.forename: M
authors.initials: M
authors.lastname: Gent
authors.forename: A
authors.initials: A
authors.lastname: Donner
authors.forename: B
authors.initials: B
authors.lastname: von Graffenreid
authors.forename: G
authors.initials: G
authors.lastname: Murphy
authors.forename: D
authors.initials: D
authors.lastname: Heinrichs
authors.forename: M R
authors.initials: MR
authors.lastname: Jenner
authors.forename: P A
authors.initials: PA
authors.lastname: Keown
authors.forename: A
authors.initials: A
authors.lastname: Laupacis
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002096:C-Peptide / Q000032:analysis; D002648:Child; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D010865:Pilot Projects
chemical_list: D002096:C-Peptide; D003524:Cyclosporins; D007328:Insulin